Biocom - Life Sciences Association of California
San Diego  |   Los Angeles  |   Washington, DC  |   Tokyo

Venture Days

VC-Days_Event1.jpg VC-Days_Event2.jpg VC-Days_Event3.jpg

Biocom Venture Days are designed to connect member companies to Venture Capitalists from around the US.

Each event, organized by the Biocom Capital Development Committee, will feature a small group of VCs that come to San Diego for a day of 1:1 meetings with select companies. Companies will be selected by the VCs based on their investment criteria and scheduled 45 minute meetings/presentations with the VCs and company executives.  

Upcoming Venture events:

Biocom Venture Day: Novo Ventures in Los Angeles

Interested in the latest developments in the venture capital market?  Looking to raise money?  Join us in Los Angeles on Tuesday, July 11th with Novo Ventures (US) for a series of one-on-one meetings with pre-selected companies. Biocom's track record includes over 125 meetings arranged with 30+ different venture capital firms. 

About Novo:

Novo Ventures (US) is one of the most active life science venture capital investors in the world. So far, we have invested $1 Billion in more than 120 companies and successfully exited over 30 companies through trade sales and IPOs.

We proudly share our positive track record with the talented scientists and inspired entrepreneurs who convert our capital and commercial support into revolutionizing products and technologies. Together, we’re improving the lives of thousands of people around the world

Our venture capital goes to promising life science companies – private and public – whose products or research address real medical, scientific or environmental needs. As business investors, we also look for profit and growth potential.

Our investment will typically range from USD 5 to 30 million initially per transaction. In addition, we have capacity to make follow-on investments. We may invest at any stage of development – seed capital, venture capital, IPOs and public companies.

How to Apply:

If you are interested in meeting with the Novo Ventures (US), please send over a one-page non-confidential executive summary for review to Oscar Rodarte at by June 26th for consideration. 

Novo Representative:

Eric Shiozaki, PhD, Principal
Eric joined Novo Ventures (US) Inc. in San Francisco, California in 2014. Prior to joining Novo Ventures (US) Inc., Eric was a Director at Apposite Capital where he established the firm’s San Francisco office and managed its secondary direct investment activity in the US. He has also worked for Vitapath Genetics in Business Development and Strategy, and as an Associate at Burrill & Company where he was a member of the firm’s venture capital practice. Before entering venture capital, Eric was a Leukemia & Lymphoma Society Post-Doctoral Fellow at UCLA. While conducting his post-doctoral research, he also spent time in the University’s technology transfer office.

Eric received a PhD in Molecular Biology from Princeton University, and a BA in Biophysics from Johns Hopkins University.

To date we have held events with:

5amVentures_Logo_VC.jpg Abingworth_Logo_VC.png AislingCapital_Logo_VC.jpg AmgenVentures_Logo_VC.jpg AppositeCapital_Logo_VC.jpg astellas_Logo_VC.jpg AvalonVentures_log_VC.jpg BASF_Logo_VC.jpg Cambia_Logo_VC.jpg CanaanPartners_Logo_VC.png clarus_logo.png FidelityVentures_Logo_VC.jpg FrazierHealthcare_Logo_VC.jpg InterwestPartners_Logo_VC.png KapyonVentures_logo_VC.jpg LongitudeCapital_Logo_VC.jpg MedImmuneVentures_Logo_VC.jpg NEA_Logo_VC.jpg novo_logo.gif Novartis_Logo_VC.jpg OrbiMed_Logo_VC.jpg Psilos_Logo_VC.jpg SanderlingVenture_logo_VC.jpg SoffinnovaVentures_Logo_VC.jpg SRone_Logo_VC.jpg TPGBioTechlogo.gif VantagePointCapitalPartners_logo_VC.jpg VersantVentures_Logo_VC.jpg

Upcoming Capital Development Events
Partnering Day with Boehringer Ingelheim
September 21, 2017
2:00 PM
Partnering Day with Eli Lilly and Company
October 3, 2017
3:00 PM

"The day could not have been better organized! The lunch was fun, my fellow VC companions were excellent, the companies we met with were interesting and diverse and the cap off dinner was absolutely lovely (and delicious)!"

Nina Kjellson

InterWest Partners